Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Journal of Molecular and Cellular Cardiology
|
May 4, 2015
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2
Hui Wang, Yimu Lai, Bryan J Mathis, et al.
Plos One
|
August 5, 2015
Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway
Fei Wu, Haibo Song, Yuan Zhang, et al.
Plos One
|
June 30, 2016
Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction
Yuzhu Zhang, Qian Mu, Zheng Zhou, et al.
Acta Pharmaceutica Sinica. B
|
July 15, 2026
Dual-driven by regulatory science and policy reconstruction: Traditional Chinese medicine (TCM) new drugs accelerate development-A critical review of highlights in registration and regulation of TCM and natural medicine new drugs in China (2021-2025)
Junning Zhao, Qiang Zhang, Shilin Chen, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Journal of Molecular and Cellular Cardiology
|
May 4, 2015
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2
Hui Wang, Yimu Lai, Bryan J Mathis, et al.
Plos One
|
August 5, 2015
Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway
Fei Wu, Haibo Song, Yuan Zhang, et al.
Plos One
|
June 30, 2016
Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction
Yuzhu Zhang, Qian Mu, Zheng Zhou, et al.
Acta Pharmaceutica Sinica. B
|
July 15, 2026
Dual-driven by regulatory science and policy reconstruction: Traditional Chinese medicine (TCM) new drugs accelerate development-A critical review of highlights in registration and regulation of TCM and natural medicine new drugs in China (2021-2025)
Junning Zhao, Qiang Zhang, Shilin Chen, et al.
Page
of 8